Machine Learning to Refine Selection Criteria of PostOperative Radiotherapy for Resectable Stage III-N2 NonSmall Cell Lung Cancer

被引：0
|
作者：
Zarinshenas, R. [1 ]
Ladbury, C. J. [1 ]
Mcgee, H. M. [1 ]
Raz, D. [2 ]
Erhunmwunsee, L. [2 ,3 ]
Pathak, R. [4 ]
Glaser, S. M. [1 ]
Salgia, R. [4 ]
Williams, T. M. [1 ]
Amini, A. [1 ]
机构：
[1] City Hope Natl Med Ctr, Dept Radiat Oncol, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Surg, 1500 E Duarte Rd, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Dept Populat Sci, 1500 E Duarte Rd, Duarte, CA 91010 USA
[4] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, 1500 E Duarte Rd, Duarte, CA 91010 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2893
引用
收藏
页码：E400 / E400
页数：1
相关论文
共 50 条
  • [1] Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Lei, Tianyu
    Li, Jing
    Zhong, Hao
    Zhang, Huibo
    Jin, Yan
    Wu, Jie
    Li, Lan
    Xu, Bin
    Song, Qibin
    Hu, Qinyong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] The effect of postoperative radiotherapy on the survival of patients with resectable stage III-N2 non-small-cell lung cancer: a systematic review and meta-analysis
    Zhang, H.
    Zhang, D. X.
    Ju, T.
    Zhou, J.
    NEOPLASMA, 2019, 66 (05) : 717 - 726
  • [3] Importance of tumor size in resectable stage III-N2 non-small cell lung cancer
    Castro, Pablo Perez
    de Perrot, Marc
    Chua, Yang Chong
    Bezjak, Andrea
    Leighl, Natasha
    Darling, Gail
    Pierre, Andrew
    Yasufuku, Kazuhiro
    Cypel, Marcelo
    Waddell, Thomas
    Donahoe, Laura
    Yeung, Jonathan
    Keshavjee, Shaf
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 164 (03): : 629 - 636
  • [4] Machine learning to refine prognostic and predictive nodal burden thresholds for post-operative radiotherapy in completely resected stage III-N2 non-small cell lung cancer
    Zarinshenas, Reza
    Ladbury, Colton
    McGee, Heather
    Raz, Dan
    Erhunmwunsee, Loretta
    Pathak, Ranjan
    Glaser, Scott
    Salgia, Ravi
    Williams, Terence
    Amini, Arya
    RADIOTHERAPY AND ONCOLOGY, 2022, 173 : 10 - 18
  • [5] Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients
    Gao, Fei
    Li, Nan
    Xu, YongMei
    Yang, GuoWang
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [6] Management of Resectable Stage III-N2 Non-Small-Cell Lung Cancer (NSCLC) in the Age of Immunotherapy
    Mielgo-Rubio, Xabier
    Montemuino, Sara
    Jimenez, Unai
    Luna, Javier
    Cardena, Ana
    Mezquita, Laura
    Martin, Margarita
    Counago, Felipe
    CANCERS, 2021, 13 (19)
  • [7] International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?
    Putora, Paul Martin
    Leskow, Pawel
    McDonald, Fiona
    Batchelor, Tim
    Evison, Matthiew
    ERJ OPEN RESEARCH, 2020, 6 (01)
  • [8] POSTOPERATIVE RADIOTHERAPY IN RESECTED YPN2 STAGE III-N2 NON-SMALL CELL LUNG CANCER: CAN MODERN CONFORMAL RADIOTHERAPY COMPENSATE FOR THE POOR OUTCOME?
    Billiet, C.
    Gouw, Z.
    Defraene, G.
    Decaluwe, H.
    Peeters, S.
    Vansteenkiste, J. F.
    De Leyn, P.
    Dooms, C.
    De Ruysscher, D.
    ANNALS OF ONCOLOGY, 2014, 25
  • [9] Trimodal Therapy of non-small cell Lung Cancer in Stage III-N2
    Askoxylakis, V.
    Tanner, J.
    Nicolay, N.
    Rief, H.
    Bischof, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 91 - 91
  • [10] Stage III-N2 Non-Small Cell Lung Cancer - Choice of Chemotherapy Schemes
    Felip, E.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S18 - S19
12345